apixaban teva 5 mg
teva pharmaceuticals slovakia s.r.o., slovensko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
apixaban teva 2,5 mg
teva pharmaceuticals slovakia s.r.o., slovensko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
polapix 5 mg filmom obalené tablety
warszawskie zaklady farmaceutyczne polfa s.a., poľsko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
polapix 2,5 mg filmom obalené tablety
warszawskie zaklady farmaceutyczne polfa s.a., poľsko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
depratad 60 mg
adamed pharma s.a., poľsko - duloxetín - 30 - antidepressiva
depratad 30 mg
adamed pharma s.a., poľsko - duloxetín - 30 - antidepressiva
dasatinib mylan 100 mg
mylan ireland limited, Írsko - dasatinib - 44 - cytostatica
dasatinib mylan 70 mg
mylan ireland limited, Írsko - dasatinib - 44 - cytostatica
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastické činidlá - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
apixaban stada 5 mg
stada arzneimittel ag, nemecko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)